Clinical Trial Update: Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone [Phase 2]

View source ↗

Summary

This update notes a Phase 2 adaptive platform trial evaluating vilazodone for post-traumatic stress disorder, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

Sponsor: Global Coalition for Adaptive Research | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: NOT_YET_RECRUITING